(Q47948046)

English

Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity.

scientific article published on 5 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

0 references

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

lactose intolerance

1 reference

based on heuristic

inferred from title

author name string

J Yang

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

M Fox

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Y Cong

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

H Chu

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

X Zheng

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Y Long

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

M Fried

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

N Dai

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

language of work or name

0 references

publication date

5 December 2013

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

39

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

302-311

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Review article: lactose intolerance in clinical practice--myths and realities.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

National Institutes of Health Consensus Development Conference: lactose intolerance and health

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Visceral hypersensitivity and intolerance symptoms in lactose malabsorption.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Is the subjective perception of lactose intolerance influenced by the psychological profile?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

The role of mast cells in common gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12582

21 January 2018

Identifiers

10.1111/APT.12582

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/24308871

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47948046&oldid=1521516350"